Judge Denies Injunction For Tyvaso Drug Competitor
IP Law 360
MARCH 29, 2024
Food and Drug Administration from approving a new competitor to its blockbuster pulmonary hypertension medication Tyvaso, saying the company was effectively seeking to challenge an agency action before the FDA made one. federal judge Friday denied drugmaker United Therapeutics Corp.'s
Let's personalize your content